MedPath

Effect of L-carnitine on insulin resistance

Phase 3
Recruiting
Conditions
Ischemic stroke.
Cerebral infarction
Registration Number
IRCT20200509047365N1
Lead Sponsor
Esfahan University of Medical Sciences
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Recruiting
Sex
All
Target Recruitment
40
Inclusion Criteria

Age of 18 years or older
Diagnosis of ischemic stroke

Exclusion Criteria

A diagnosis of hemorrhagic stroke
History of hypersensitivity to L-carnitine
History of taking L-carnitine in the last month
Required dialysis

Study & Design

Study Type
interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Determination and comparison of mean insulin resistance before and after intervention. Timepoint: Before intervention and 7 days after intervention. Method of measurement: Homeostatic model assessment of insulin resistance (HOMA-IR).;Determination and comparison of Prognosis of two groups. Timepoint: Daily from day 1, before intervention to day 7 and 28 days after intervention. Method of measurement: Frequency of 28-day mortality and duration of mechanical ventilation, daily Glasgow Coma Scale and Sequential Organ Function Assessment scores, whether or not sepsis occurs through the intervention days based on SOFA score changes.
Secondary Outcome Measures
NameTimeMethod
© Copyright 2025. All Rights Reserved by MedPath